Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro-Reference-Cited by-同舟云学术

Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro

Published:2012 Issue:8 Volume:18 Page:BR293-BR298
ISSN:1234-1010
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Lü Jian-Ming¹,Yan Shaoyu¹,Jamaluddin Saha¹,Weakley Sarah M.¹,Liang Zhengdong¹,Siwak Edward B.²,Yao Qizhi³,Chen Changyi¹

Affiliation:

1. Michael E. DeBakey Department of Surgery, Molecular Surgeon Research Center, Baylor College of Medicine, Houston, Texas, U.S.A.

2. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, U.S.A.

3. Michael E. DeBakey Department of Surgery, Molecular Surgeon Research Center, Baylor College of Medicine, Houston, Texas, U.S.A. and Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, U.S.A.

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity;Scientific Reports;2024-04-08

2. In Vitro, In Vivo, and In Silico Activities of Ginkgolic Acid C15:1 against Streptococcus agalactiae Clinical Isolates;ACS Infectious Diseases;2023-09-11

3. An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets;Archives of Microbiology;2023-03-07

4. Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay;International Journal of Biological Macromolecules;2023-01

5. Expanding the antiviral potential of the mosquito lipid‐transfer protein AEG12 against SARS‐CoV ‐2 using hydrophobic antiviral ligands;FEBS Letters;2022-08-04